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IDENTIFICATION OF ACTH IN HUMAN
PLACENTAL TISSUE*
JEANETTE C. OPSAHL AND C. N. H. LONG
Studies from the laboratory have revealed the presence of ACTH activity
in extracts of pregnancy urine which had been heat-treated to destroy
gonadotrophic activity.7 These observations led to the investigation of
placental extracts to ascertain whether the source of the ACTH activity
was the placenta rather than the pituitary gland. Certain of the results
obtained are reported in this paper.
Although the crude methods of extraction employed do not permit
quantitative interpretation of yields, the results of this study indicate that
significant quantities of ACTH are produced by the placenta. ACTH activ-
ity in extracts from placental tissue has recently been described by
Tarrantino8 and in an isolated study by Jailer and Knowlton.8
Identification of the type of activity found in the various fractions of
placental extracts is based in this present instance upon previous work from
thislaboratory. Inhibition of the enzyme, hyaluronidase, byadrenal steroids
has been shown to be a normal, physiological mechanism and some of the
pharmacological effects observed following the administration of extremely
large amounts of adrenal hormones may possibly be related to their influ-
ence upon this complex enzyme system. Further, ACTH, presumably
through its ability to stimulate the release of effective C-11 steroids, was
found to be a potent inhibitor of the hyaluronidase-enhanced spreading
phenomenon. And finally, a correlation has been obtained between the
ability of the C-11 adrenal steroids to inhibit the hyaluronidase-enhanced
spreading phenomenon, and in vitro inactivation of hyaluronidase as
measuredbytheinhibition of the release of reducing sugars from hyaluronic
acid. These concepts have provided in part the basis for the following
experiments.
MATERIALS AND METHODS
Placentas were obtained immediately after delivery.t At first, the placentas were
extracted in either of two ways-(i) the placenta was directly frozen in dry ice, stored
for one day, and then ground and extracted, or (ii) the still warm placental tissue and
blood were ground immediately, and further studies were carried out without interven-
ing lapse of time. The crude dry powders obtained from extraction of frozen placentas
were found to possess a markedly lower degree of activity, and much lower yields
were obtained from them.
* From the Department of Physiological Chemistry, Yale University. This investi-
gation was supported by Contract Nonr-592(00), Office of Naval Research.
t We are gratefully indebted to Miss Lenox and the Department of Obstetrics and
Gynecology, Yale University School of Medicine, for their co-operation in making the
various placentas available to us directly after delivery.
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In part, Lyons' procedure4 for the extraction of mammotropic hormone from pituitary
tissue was employed. While based on speculation, it seemed possible that the major
portion of ACTH, if present, would be found in the tissue residue rather than in the
original acetone-HCl supernate. Hence, the usually discarded acetone residue of tissue
and blood was further examined. In determining the properties of the fractional
precipitates in terms of activity and toxicity, as a basis for establishing further experi-
mental procedures, the original extractions were made without reference to quantitative
yields, pH, or HCl concentration.
The methods for obtaining Fractions I and II were as follows: Fresh, still warm,
whole placental tissue and blood (weighing altogether about 1 kg.) were put through
a power grinder within a half hour following delivery, and 4 liters of acetone containing
100 ml. of 35% HCl were added to the semi-solid mass; this was mixed thoroughly for
two to four hours and then centrifuged. The supernate was decanted, combined with
5 liters of fresh acetone, and agitated (using a mechanical stirrer) overnight in the
cold room. The precipitate was separated by centrifugation, redissolved in a small
amount of water, and again precipitated with acetone. This reprecipitation was re-
peated 4 times, with the final dry yield approximately 15 grams. This precipitate was
designated Fraction I.
Because of the high water content of the placental tissue and blood, and the likelihood
that the major portion of the ACTH activity might remain in the first acetone residue
discarded in obtaining Fraction I, further extraction of this residue was made. The
tissue residue remaining after the original acetone extraction was suspended in 1 liter
of water, mixed well, and stored in the cold room over night. The solid portion was
separated by squeezing the mixture through fine cheese cloth. To the liquid fraction,
4 liters of acetone (no HCI) were added. The precipitate which formed was separated
by centrifugation, dissolved in water, and reprecipitated with acetone; this procedure
was repeated three times. The final product, when acetone-dried, yielded 25 grams,
and was designated Fraction II. By reducing the time of the original acetone extrac-
tion of the placental tissue to 15-30 minutes, the weight yield of the final dried Fraction
II could be increased considerably with no decrease in activity; for example, average
yields of 65 grams of Fraction II and 16 grams of Fraction I could be obtained from
individual placentas.
The resulting dry powders were dark to light grey in color, and were very water
soluble (example, 10 mg./ml.). These preparations were stored in vacuo. The results
of other extraction procedures and further purifications of the extracts will be re-
ported in a subsequent paper.
Fresh beef muscle was ground and extracted in the manner as described for obtain-
ing the Fractions I and II from placental tissue. The beef muscle fractions were com-
bined and their effect on the spreading reaction was determined.
Serum albumin* was used as a further control substance; the final dilutions were
made from a sterile solution containing 25 mg./ml.
The test substances, placental fractions I and II, beef muscle extract, and serum
albumin, were dissolved in physiological saline, and volumes of 0.2 to 1.0 ml. were
injected intraperitoneally. The amounts administered varied from 0.5 to 10.0 mg., and
the results were determined after varying time intervals of absorption in normal,
adrenalectomized, hypophysectomized, and hypophysectomized-adrenalectomized mice.
Equal amounts of saline were injected into control groups of mice, and control studies
were routinely made. The experimental animals were set up in groups of equal numbers
of males and females. There was no difference with mice of different sex, nor did the
volume of diluent used exert any effect on the results.
* The vial of sterile serum albumin was kindly supplied by Dr. H. B. Vickery of the
Connecticut Agricultural Experiment Station.
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In other experiments, to determine whether or not a local inhibitory effect could
be obtained, amounts of 0.05 to 5.0 mg. of the fractions of placental extract were in-
jected intradermally in normal and adrenalectomized mice, either simultaneously with,
or just prior to, the injection of the hyaluronidase and India-ink mixture. The pro-
cedures and methods of measurement employed in the hyaluronidase assays have been
described in previously published studies."'
Male and female mice of the inbred CBA strain,, 10-12 weeks of age and weighing
from 25-30 grams were used. Adrenalectomized mice were tested one or six days after
adrenalectomy and were not maintained with extra sodium chloride. Hypophysectomized
mice of both sexes were used 48 hours after operation; these mice were fed laboratory
chow ad libitum and were given 5% glucose in physiological saline to drink. Examin-
ation at autopsy showed the completeness of hypophysectomy and only a slight degree
of weight loss and adrenal atrophy.
Since the major inhibitory effects have been found on the hyaluronidase-enhanced
areas of spreading, this method of reporting results has been used in most of the studies
described in this paper. However, in the testing of placental extracts, control injections
of saline and India ink alone were compared with the hyaluronidase-enhanced areas
of spreading, thus providing a means of semi-quantitive estimation of the inhibition of
exogenously added enzyme (see Table 3). The significance of these determinations
has been discussed in another publication.6
Standardized preparations of testicular hyaluronidase obtained from Dr. Joseph
Seifter of Wyeth Inc. were used. Preparations were designated W-108-A, W-109-A,
and W-160-A, and varied markedly in degree of spreading activity.
ACTH preparations designated by Armour as H-8412 were used. The contents of
one vial was stated to contain an amount equivalent to 35 mg. LA-1-A and to contain
0.2 unit oxytocin and 0.14 unit pressor substance.
The preparations and potency of the human chorionic gonadotrophin and heat-
inactivated chorionic gonadotrophin preparations have been described in an earlier
publication.'
"Adrin," the Sharp and Dohme commercial brand of epinephrine, was used. Final
dilutions were made with saline.
EXPERIMENTAL
Normal animals. Table 1, a summary of representative experiments,
shows the influence of crude placental extracts on the spreading reaction.
Inhibition of hyaluronidase-enhanced spreading resulted when mice were
injected intraperitoneally with amounts of 1 to 10 mg. of the crude placental
fractions I and II. Control groups of mice were injected with saline alone.
When 1 mg. ofFraction II is injected, a marked inhibition of hyaluronidase-
enhanced spreading was observed with roughly a 60% inhibition of added
enzyme. When 5 mg. were injected, essentially maximal inhibition of
spreading was observed, while complete inhibition of added enzyme was
obtained; 10 mg. of Fraction II caused no greater inhibition and produced
no toxic effects. With Fraction I, 1 mg. caused a slight but consistent
degree of inhibition of spreading, 5 mg. produced an average of 40 per cent
inhibition of spreading (72%o inhibition of enzyme), while 10 mg. of
Fraction I were necessary to obtain maximal inhibition of spreading and
complete inhibition of enzyme. Consistently, Fraction II has proved twice
as active as Fraction I.
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With doses of less than 0.5 mg. of placental fractions I and II, it was
impossible to detect hyaluronidase-inhibiting activity; however, in control
studies of inhibition it has been consistently seen that large doses of ACTH
must also be used, and amounts of ACTH of less than 0.5 mg. were simi-
larly ineffective. Further, administration of 5 mg. of Fraction II produced
TABLE 1
INFLUENCE OF SYSTEMICALLY ADMINISTERED PLACENTAL EXTRACT FRACTIONS, BEEF MUSCLE
EXTRACT, AND SERUM ALBUMIN ON THE DERMAL SPREADING OF
INDIA INK WITH HYALURONIDASE*
I. NORMAL ANIMALS
Substance
injected
Fraction I
Fraction II
Fraction II
Fraction I
Fraction II
Fraction I
Fraction II
Fraction II
Serum Albumin
Serum Albumin
Serum Albumin
Tissue Extract
Tissue Extract
Tissue Extract
Dose**
Mg.
1
1
1
5
5
10
10
10
1
5
10
1
5
10
Time Time of
between enzyme
injection spread-
and test ing
Hours Hours
3 3
1 3
1 24
3 3
3 3
3 3
3 3
3 3
3 3
3 3
3 3
3 3
3 3
3 3
Area ofspreading
Controls
Sq. mm.
534(18)
535(12)
750(12)
534(18)
534(18)
623(12)
623(12)
810*(12)
540(12)
540(12)
540(12)
530(12)
530(12)
530(12)
Experimental
Sq. mm.
450(12)
355(12)
510(12)
315(12)
252(12)
272(12)
250(12)
265(12)
570(12)
603(12)
630(12)
592(12)
578(12)
590(12)
*Enzyme with increased spreading activity used. The increased spreading activity had no
effect on the subsequently determined maximal degree of inhibition produced, which represented
essentially 100%o inhibition of added enzyme.
** Intraperitoneal administration. Diluent = 1.0 ml. physiological saline. Control groups were
injected with equal volumes of saline alone.
t See Table 3.
the same maximal degree of inhibition of spreading as was obtained with
no less than 3.5 mg. of ACTH from the pituitary.
Administration of 1, 5, and 10 mg. amounts of beef muscle extract or
serum albumin wascompletelywithout inhibitory effect on the hyaluronidase-
enhanced areas of spreading.
While factors of non-specificity or toxicity reactions have been essentially
ruled out as an explanation for the observed effects following administra-
tion of placental fractions, numerous experiments have also shown that
toxic doses of colchicine, spermine, formaldehyde, and certain bacterial
agents exert little or no effect in producing inhibition of hyaluronidase-
% Inhibi-
tionof
added
enzymet
--44
-62
-72
-98
-94
-99
-96
% Change
from
control
-16
-34
-32
-40
-53
-56
-60
-67
+ 5
+12
+17
+ 1
+ 8
+11
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enhanced spreading. Although the placental extract fractions might con-
ceivably provoke a discharge of endogenous epinephrine, it has been
demonstrated that the systemic injection of epinephrine in amounts up to
0.02 mg. per mouse produces little or no inhibitory effect. Only when doses
of 0.05 mg. or more per mouse were injected was there any degree of
inhibition, and this took place only in animals with intact adrenals
(unpublished data).
TABLE 2
INFLUENCE OF PLACENTAL ExTAcT FRACTIONS, BEEF MUSCLE EXTRACT, AND SERUM
ALBUMIN ON THE DERMAL SPREADING OF INDIA INK WITH HYALURONIDASE
II. ADRENALECTOMIZED ANIMALS
Time
between Time of Area ofspreading
injection enzyme A Change
Substance Dose and test spreading Controls Experimental from
injected* Mg. Hours Hours Sq. mm. Sq. mm. control
Fraction I 5 3 1 685(32) 670(6) -2
Fraction II 5 3 1 685(32) 695(6) +1
Fraction I 10 3 1 685(32) 850(6) +19
Fraction II 10 3 1 685(32) 730(6) +7
Serum albumin 10 3 1 685(32) 678(6) +1
Beef extract 10 3 1 685(32) 750(6) +9
* Injected intraperitoneally in volume of 1.0 ml. physiological saline. Control groups
were injected with equal volume of saline alone.
NOTE: In intradermal experiments in normal and adrenalectomized animals, these
compounds were similarly without inhibitory effect in dosages of 0.05 to 5.0 mg. injected
in the intradermal site of hyaluronidase injection, when injections of test substances
were made simultaneously with, or just prior to the injection of hyaluronidase and
India ink.
The results shown in Table 1 and Figure 1 are representative of several
series of experiments in which varying amounts and preparations from
different placentas were administrated.
Adrenalectomized animals. Investigations were undertaken to determine
the site of action of the placental extract fractions, and whether or not their
action might be related to the presence of measurable quantities of the
C-11 oxygenated adrenal steroids which are also effective in producing
hyaluronidase inhibition.
Groupsofmaleandfemale mice were tested 24 hours after adrenalectomy.
Placental extract fractions I and II dissolved in saline were administered
intraperitoneally, and, following arbitrarily selected time intervals of one
to six hours, experimental testing with hyaluronidase and India ink solu-
tions was carried out. Table 2 shows that the administration of 1 to 10 mg.
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of fractions I or II* was completely without inhibitory effect on the
hyaluronidase-enhanced areas of spreading. Serum albumin or beef muscle
extract control studies similarly showed no inhibitory effect. In the adrenal-
ectomized animal, cortisone in doses of 0.5 mg. was found effective in
producing a marked degree of hyaluronidase inhibition at short post-
absorptive time intervals, and Compound F in similar dosages at the longer
absorption time intervals was also effective. This would suggest that the
activity of these placental extracts was not due to the presence in them- of
any significant quantities of cortisone or Compound F.
Intradermal experiments in normal and adrenalectomized animals. Intra-
dermal injection of the various placental extract fractions was made in the
same site as the injection of hyaluronidase and India ink mixture. The
placental fractions were dissolved in saline and combined with the
hyaluronidase and India ink solution, or injected just prior to the admin-
istration of the enzyme-India ink mixture. The amounts of placental extract
injected ranged from 0.05 to 5.0 mg., under the various experimental con-
ditions, and the resulting areas of spreading were measured after time
intervals of one to sixteen hours. There was no evidence of inhibition of
hyaluronidase-enhanced spreading. Since it has been shown that 0.05 mg.
of Compounds E or F, or 0.025 ml. of ACE administered intradermally
will markedly inhibit hyaluronidase,' the lack of effect produced by large
amounts of placental fractions administered intradermally would again
indicate the absence of appreciable amounts of the C-il steroids in the
fractions tested.
Hypophysectomized animals. Critical evaluation of the action of these
placental extract fractions was obtained by noting their effect on the
spreading reaction in hypophysectomized animals. The effects produced by
the injection of 1 to 10 mg. of various placental fractions in 48-hour hypo-
physectomized mice are shown in Table 3 and graphically illustrated in
Figure 2. Again, the greater activity of Fraction II is demonstrated. Five
mg. of Fraction II or 10 mg. of Fraction I or II produced essentially maxi-
mal inhibition of hyaluronidase spreading, with complete inhibition of
added enzyme. Inhibition of hyaluronidase did not occur when 1 to 10 mg.
of serum albumin or beef muscle extract were administered to groups of
hypophysectomized animals.
Potentiation of the hyaluronidase-enhanced spreading appeared to be
greater in hypophysectomized animals than was the case with normal ani-
mals. It is interesting that hypophysectomized animals better tolerated
stress and large doses of these test substances than did adrenalectomized
animals under identical experimental conditions. For example, hypo-
*Five and 10 mg. amounts of Fractions I and II were not toxic to the 24-hour
adrenalectomized animal; however, the 10 mg. doses proved fatal to the 6-day
adrenalectomized animal and in comparison, 5 mg. pituitary ACTH were fatal.
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physectomized mice, tested 48 or 96 hours after operation, tolerated without
toxic effect doses of 10 mg. of placental extracts, whereas the six-day
adrenalectomized animal was killed by 5 mg. ACTH or by 10 mg. of the
placental fractions.
A group of hypophysectomized-adrenalectomized animals was given 5
mg. amounts of placental fractions I and II, and hyaluronidase testing
TABLE 3
INFLUENCE OF SYSTEMICALLY ADMINISTERED PLACENTAL EXTRACT FRACTIONS, BEEF MUSCLE
EXTRACT, AND SERUM ALBUMIN ON THE DERMAL SPREADING OF
INDIA INK WITH HYALURONIDASE
III. HYPOPHYSECTOMIZED ANIMALS
Time Time of
between enzyme % Inhibi-
injection spread- Area ofspreading % Change tion of
Substance Dose* and test ing Controls Experimental from added
injected Mg. Hours Hours Sq. mm. Sq. mm. control enzyme**
Fraction I 2.5 3 3 655(18) 422(6) -36 55
Fraction II 1 3 3 655(18) 392(6) -40 65
Serum albumin 1 3 3 655(18) 657(4) +
Fraction I 5 3 3 655(18) 302(6) -54 -86
Fraction II 5 3 3 655(18) 244(6) -63 -100
Beef Extract 5 3 3 655(18) 670(4) + 1
Fraction I 10 3 3 655(18) 268(6) -59 94
Fraction I 10 3 3 650(12) 275(6) -58 -94
Fraction II 10 3 3 650(12) 270(6) -58 -94
Serum albumin 10 3 3 650(12) 630(6) - 3
Beef Extract 10 3 3 650(12) 680(6) + 5
* Intraperitoneal injection in volume of 1.0 ml. saline. Control groups received equal volumes
of saline alone.
** Method of calculation:
Example: Control injections of saline and India ink, average area of spreading (24)
= 245 sq. mm.
655 - 245 = 410. Spreading in sq. mm. due to hyaluronidase before testing.
268 - 245 = 23. Spreading in sq. mm. due to hyaluronidase after testing.
Per cent inhibition of added enzyme = 410 - 23 = 387; 387 X o00 = 94%.
carried out as above described. As in the case of the adrenalectomized
animals, no inhibition of hyaluronidase-enhanced spreading was produced.
Although the placental extracts were extremely crude, it is interesting
that the maximal degree of inhibition produced with the placental fractions
was comparable to that observed with relatively similar amounts of pitui-
tary ACTH. The constant degree of inhibition of spreading in the hypo-
physectomized animals, with extracts made from different placentas, is to
be noted.
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Effect on adrenal ascorbic acid. In view of the wide acceptance of adrenal
ascorbic acid depletion as an indirect measurement of adrenal activity, the
effects of placental extracts on the adrenal ascorbic acid levels of a small
number of hypophysectomized rats and mice were determined. In hypo-
physectomized rats the intravenous injection of 1 and 2 mg./100 gm. of
fractions I and II produced an average fall in adrenal ascorbic acid of 20%o
and 50%o, while the injection of 0.1 mg. ACTH was followed by an average
fall of 55%o. In hypophysectomized mice, 2 mg./100 gm. injected intra-
peritoneally produced an average fall of 32%o. In order to obtain sufficient
tissue for analysis, the adrenals of three mice were pooled for each deter-
mination of ascorbic acid. With the 2 mg./100 gm. dose, there was an
average eosinophil fall
EFFECT OF CO.HICG OR PLACENTAL EXTRACTS ON THE
HYALURONIDASE-ENHANCED SPREADING REACTION of 74% in both hypo-
¢ 70. physectomized mice and
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0
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30 The markedly simi-
z 20 * _ * - lar hyaluronidase-inhib-
zl3o. itory effects produced
v. °15 10 1 510 .01.02 1 3.5 I .S22 I 1 S 10 1 5 10 by the various placental
SERUM TISSUE EPINEPH. ACTH CGO) i C CFLA. ract fractions, by the
ALS3UMIN EXTRACT COmil) FR.1I FR.U. eXtratb COCIlI1) human chorionic gonad-
DOSAG E IN MS... q FOSAGE IG MS. 1otrophin preparations,'
FIG. 1. compare favorably with
the effects produced by the standardized commercial ACTH preparations
from the pituitary, in normal, adrenalectomized, and hypophysectomized
mice. A graphic summary of some of the results obtained with the use of
these preparations in normal animals is seen in Figure 1. Since Fraction II
represents material that is normally discarded in the Lyons procedure, it is
interesting that Fraction II of the placenta consistently showed a greater
degree of activity than did Fraction I, and that more than twice as large a
yield of dried powder was obtained in Fraction II. When fresh placental
tissue was extracted, the fractions were not only extremely large for the
crude procedures employed in extraction, but also possessed ACTH activ-
ity in dosage ranges comparable to those for the pituitary preparations.
However, placental tissues that had been frozen and stored prior to extrac-
tion did not yield fractions comparable in activity or quantity to those
obtained with the use of fresh placentas. Thus, a destruction of ACTH
activity is indicated, even though the tissue remained in the frozen state.
There is indication that this lability of ACTH has been observed in the
isolation of ACTH from pituitary tissue by Astwood.'
A more critical evaluation of ACTH activity in these placental extracts
is seen in Figure 2, which is a graphic summary of results from experi-
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ments using hypophysectomized animals. The marked inhibitory effect of
the chorionic gonadotrophins and heat-inactivated chorionic gonadotrophin
preparations is seen in comparison with results obtained with the crude
placental preparations. To indicate further the extent of hyaluronidase
inhibition, the results with the placental extract fractions are presented as
per cent of actual inhibition of exogenously added hyaluronidase, following
the calculation procedure illustrated in Table 3.
Theplacental tissue fractions caused a marked inhibition of hyaluronidase
in both normal and hypophysectomized animals, and with the larger
dosages this inhibition approximated 100%o inactivation of added enzyme.
In all cases the placental
EFFECT OF CG. HICG OR PLACENTAL EXTRACTS ON THE
extracts were inactive in HYALURONIDASE-ENHANCED SPREADING REACTION
adrenalectomized animals, '00
and since the inactivation 90 HYPOPHYSECTOMIZED MICE
z
INHIBITION OFENZYMEm was uniform, this type of a 60 T O
experiment was not included 70
in these figures. The posSl- X 60
bility that the observed ac- z 50:
tivity was due in any way t
to the presence of steroids x 30
of the nature of cortisone is 20
ruledoutby the fact that en-
zyme inhibition was not ob- X '
served in adrenalectomized 0 5 o 5 10 13 3 3 2.5 510 5 10
SERUM TISSUE CG(II) HICOCI) PLAC. PLAC. or hypophysectomized- ALBUMIN EXTRACT CGti) FR.? FR.=.
adrenalectomized animals, DOSAGE IN MG.
and by the fact that the FIG. 2.*
placental tissue extracts were without effect when administered intra-
dermally at the site of hyaluronidase injection. Non-specificity was ruled
out by the lack of effectiveness of meat extracts and serum albumin, and
further supporting this conclusion are the results of numerous studies
showing that toxic substances such as formaldehyde, spermine, colchicine,
and bacterial agents did not elicit an inhibition of hyaluronidase in the
normal or adrenalectomized animal. Epinephrine, in amounts of 0.02 mg.
or less per mouse, did not influence the spreading reaction.
These studies on ACTH activity of placental tissue indicate that the
placenta contains relatively large amounts of the hormone. In addition,
even though the preparations were extremely crude, there was a striking
lack of toxicity with their administration. Since the material is of human
* The more marked inhibitory effect noted with the use of the heat-inactivated
chorionic gonadotrophin preparation is due to the fact that a high spreading potency
enzyme was employed to test the quantitative aspects of degrees of enzyme inhibition
that could be produced. In both types of enzyme testing, essentially 100%o inhibition
of the exogenously added enzyme was found to have taken place.
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origin and presumably would not cause a foreign protein reaction when
administered to humans, it is possible that placental ACTH would have an
important practical value as there have been recent reports by Feinberg'
and Thorn9 of sensitivity to pituitary ACTH preparations. The observation
that ACTH activity is obtained with placental extracts is in agreement
with the previous report that human pregnancy urine preparations, heated
to destroy gonadotrophic activity, possess ACTH activity.' These gonado-
trophins excreted in the urine during pregnancy have their origin in the
placenta,'0 and it is probable that the placental extracts contained the
precursor of these excretory products.*
The technique of measuring hyaluronidase inhibition has been developed
to the point where it can be applied on a semi-quantitative basis, and has
been used as the principal type of evidence for the measurement of ACTH
and adrenal steroid activity in this series of studies. However, the pertinent
points involved in the establishment of ACTH activity in these placental
extract fractions by measurement of hyaluronidase inhibition in the normal,
adrenalectomized, or hypophysectomized mouse have been substantiated by
studies on adrenal ascorbic acid depletion. In the studies by Tarrantino8
and by Jailer and Knowlton,' depletion of adrenal ascorbic acid has been
used as the criterion of ACTH potency. On the basis of these assays, it
would appear that extremely large amounts must be administered in order
to obtain a significant decrease in adrenal ascorbic acid; however, the gross
impurities of the crude extracts must be considered. At the same time, it
has been noted that large doses of chorionic gonadotrophins also have to be
used in order to obtain adrenal ascorbic acid decreases that are significant.
On the other hand, when inhibition of hyaluronidase-enhanced spreading
in the hypophysectomized mice is used as a criterion of ACTH activity, the
preparations just referred to appear to possess roughly the same order of
activity as pituitary ACTH, Armour LA-1-A.
Inasmuch as the experiments herein presented definitely show that there
is an adrenal trophic effect, and since epinephrine has been excluded from
consideration as a mediator of this action, one must conclude that the effect
in all probability is trophic for the adrenal cortex. It is therefore quite
appropriate to speak of placental ACTH as a substance which causes the
adrenal to produce a factor or factors which inhibit hyaluronidase, but
it is not necessary to assume that this placental ACTH has the same
physiological characteristics as does pituitary ACTH.
* Urinary excretion of material possessing ACTH activity is not restricted to preg-
nancy, since the substance, urogastrone, which possesses many of the chemical properties
of chorionic gonadotrophin but which does not have gonadotrophic activity, isolated
from normal human male urine, also causes an inhibition of hyaluronidase (unpublished
data). It must be remembered that the quantity of material identified as urogastrone in
male urine is extremely small, and considerably increases in urine of pregnancy. It is
quite possible that the urogastrone isolated from normal male urine originates in the
anterior pituitary.
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It is obvious that the observations recorded in this paper pose a multitude
ofquestions thatmust be answered before the relationship between placental
and pituitary ACTH can be understood.
SUMMARY
Experimental evidence indicates the presence of ACTH in varying
fractions of placental tissue and shows that it is produced in large quantities
by this organ. The Lyons' procedure for extraction of ACTH from pitui-
tary tissue is not applicable to the extraction of ACTH from placental
tissue and blood.
Administration of various fractions of crude placental extracts to normal
or hypophysectomized mice produces a marked inhibition of hyaluronidase-
enhanced spreading with essentially complete inhibition of exogenously
added enzyme. These fractions are completely without effect in adrenal-
ectomized mice and are without effect when injected intradermally at the
site of the hyaluronidase injection.
The inhibitory effect of placental extracts is not due to the presence in
them of measurable quantities of steroids of the adrenal cortical type
(cortisone or Compound F).
There is a similarity between the inhibitory effects produced by the
placental fractions and the results following administration of pituitary
ACTH, chorionic gonadotrophins, and heat-inactivated chorionic gonado-
trophins.
The presence of ACTH activity in placental extracts is also shown by
the depletion of adrenal ascorbic acid and a fall in circulating eosinophils
that occurs after their injection into hypophysectomized rats and mice.
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